Skip links

Soliris® (eculizumab)

Full Name Soliris® (eculizumab)
Drug Soliris
Manufacturer Alexion Pharmaceuticals, a subsidiary of AstraZeneca
Route of Administration Intravenous
Site of Care Home or Healthcare Facility
Approved Indication The treatment of patients with paroxysmal nocturnal hemoglobinuria (PNH) to reduce hemolysis
Disease Paroxysmal Nocturnal Hemoglobinuria (PNH); Atypical Hemolytic Uremic Syndrome (aHUS)
Therapeutic Area Hematology
Enrollment Form Link Soliris Enrollment Form
Phone Number N/A
Fax Number N/A
Product Website